(Q41015103)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

adaptive radiation therapy

16 May 2024

main subject

0 references

author name string

G. K. Zagars

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7523725

16 May 2024

language of work or name

English

0 references

publication date

1 November 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 October 2019

https://api.elsevier.com/content/article/PII:S0022534717323868?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

https://api.elsevier.com/content/article/PII:S0022534717323868?httpAccept=text/plain

16 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2932386-8

16 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

16 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

5 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

1786-1791

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy

20 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

16 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

16 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

16 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy

16 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup.

16 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapy

16 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

16 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy

16 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate

16 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy

16 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Prostate-specific antigen and external beam radiation therapy in prostate cancer

16 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

16 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

16 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

16 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)32386-8

16 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7523725%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference